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I m d m m
Fluorescence microscopy with digital image piocessing is currently being used to investigate 
membrane structure (8). When a fluorescent probe is attached to a membrane component, such as 
phosphatidylcholine, phosphatidic acid, or a membrane protein, and the component is then 
incorporated in a lipid bilayer, monitoring the relative fluorescence intensity of the probe 
throughout the bilayer can provide one with detailed information as to the structure of the lipid 
bilayer, or membrane (8).
Previous work carried out in the laboratory has been almost exclusively involved with 
labeling a phospholipid with a fluorophore and then monitoring the fluorescence with fluorescence 
microscopy as a means of determining the distribution the phospholipid. However, the biological 
membrane contains many other components, for example, cholesterol and proteins, all of which arc 
involved in determining its structure, and thus, its function. Proteins, just as phospholipids, can be 
labeled with fluorescent probes, without seriously degrading their natural behavior. This is the 
case because proteins and phospholipids are large enough that a small fluorescent probe does not 
seriously perturb their structure. However, this would not be case with cholesterol, where the 
probe and cholesterol would be similar in size. Thus, labeling cholesterol with an exogenous 
fluorescent probe would seriously hamper a molecule like cholesterol in behaving naturally, and 
would, therefore, be useless for studying cholesterol naturally present in biological membranes.
A way to avoid this problem is to use a compound that is naturally fluorescent and behaves 
similarly to cholesterol. Dehydroergosterol, A^>9(1 l),22_Ergostatetraen-3B-ol (Figure 1), is 
such a compound. It is not a naturally occurring steroid, but has been found to behave comparably 
to cholesterol in biological membranes (11). Structurally, dehydroergosterol is very similar to
5and the fact that it contains conjugated n-bonds which allow it to fluoresce
cholesterol (Figure )*
n ideal choice for use in studying the distribution of cholesterol in model 
naturally make it an iu
biological membranes with fluorescence microscopy.
FIGURE 1: Dehydroergosterol FIGURE 2: Cholesterol
Dehydrocrgosterol can k-, . . . oe synthesized from ergosterol, a naturally occurring sterol in plants,
y e y u°n (Figure 3) n .
chromatogra h '• * he crude product is then purified using high performance liquid
pt)y (HPLC) ann
previously Synth . °  layer chromatography (TLC). This compound has not been
•zed in ^
,a<X>ratory.
FIGURE 3.
: ^Vnthe s is
^ehydroergosterol from ergosterol.
c h 3c o 2h
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6Materials and Methods
Ergosterol was purchased from Sigma Chemical Company (St. Louis, MO). 
Dehydroergosteroi was synthesized directly by the procedure given by Smutzer (1), a modification 
of the procedure originally presented by Windhaus (2).
2 grams of ergosterol were placed in a 50 ml reaction vessel. This was then dissolved in 17 
ml of glacial acetic acid and 20 ml of chloroform. To this solution was added 3 grams of mercuric 
acetate. The reaction was allowed to proceed in the dark for 24 hours under a nitrogen atmosphere. 
The mixture was kept at 37-40°C with constant stirring for the duration of the reaction. After 
completion, mercurous acetate was removed by filtering the mixture twice. The mixture was then 
concentrated by rotary evaporation to 5 ml. This final volume was then recrystnlized in ethanol, 
filtered, and washed with ice-cold ethanol. The product was then dissolved in ether and filtered 
thr > ,h Whatman No, 1 filter paper. The filtrate was placed under a stream of nitrogen to remove 
the ether. When the product was dry, it was again recrystalized in ethanol, thi:; time allowing the 
recrystallization to proceed overnight at -5°C. The product was then dried overnight under house 
vacuum. This crude product was then resuspended in chloroform and stored in the dark under 
nitrogen at -5°C.
The crude product was then purified by high performance liquid chromatography (HPLC), 
by a procedure similar to that given by Fischer et al. (3). A 10 pi sample of the crude product in 
chloroform was injected onto a reverse phase C-18 preparatory HPLC column (10.0 mm ID x 250 
mm). The column was equilibrated with methanol/acetonitrile (75:25 v/v). A flow rate of 5.0 
ml/min was used. The elution from the column was followed by monitoring absorbance at 328 
nm, and the single ped . at 12 minutes was collected, and stored in the dark under nitrogen. A 
number of HPLC runs were performed at one time (approximately 10), to obtain a sufficient 
quantity of dehydroergosteroi. When the HPLC runs were completed, the fractions obtained were 
combined.
7The dehydroergosterol was then extracted into chloroform by using a slightly modified 
version of the procedure given by Bligh and Dyer (4). To 5 ml volume of the methanol/acetonitrile 
(3/1 v/v) solution was added 3 ml of water. The solution was shaken Then 3 ml of chloroform 
were added, and the solution was again shaken. The solution was then spun in a desktop 
centrifuge for approximately 10 minutes. The top, polar, phase was drawn off. 6 ml more water 
was then added to lower, non-polar, phase, mixed, and spun for 10 minutes in a desktop 
centrifuge. The top phase was again drawn off, and the chloroform phase was then dried down 
under nitrogen to approximately one third original volume (approximately 1 ml).
This solution was then checked for purity by obtaining a fluorescence emission spectra, 'flic 
sample was excited at 327.8 nm at emission was monitored from 340 nm to 540 nm. The presence 
of a intense peak at approximately 400 nm was indicative of remaining contamination.
Therefore, the sample was further purified by thin layer chromatography (TLC). The 
product in chloroform was applied to a 250 pm Silica Gel G TLC plate which had been pre-run in 
acetone. The plate was run with hexane/diethylether/glacial acetic acid (60/20/1 v/v/v). Two 
fluorescent bands were observed. Staining the plate with iodine, in order to detect the presence of 
other bands with double bonds, revealed no additional bands. The bands where scraped and 
collected. The silica was then washed with at least 30 ml of chloroform/methanol/water (50/100/5 
v/v/v). The solution was added to the silica, thoroughly mixed, and then spun down for 5 to 10 
minutes in i desktop centrifuge. The washes were collected and the product was drawn into a 
chloroform phase by the procedure given by Bligh and Dyer (4).
This final product was then checked for purity by fluorescent excitation and emission 
spectra, and absorption spectra. Furthermore, a sample was reinjected onto a 4.6 mm ID by 250 
mm reverse phase C-18 HPLC column, equilibrated with acetonitrile/methanol (1/3 v/v), and 
followed by monitoring i bsorbance and fluorescent emission.
8Results and Discussion
rfhe sample was checked for purity by obtaining fluorescence emission and excitation 
spectra. For excitation spectra, emission at 380 nm was monitored, while the sample was excited 
from 200 nm to 360 nm, while for emission spectra the sample was excited at 320 nm, and 
emission was monitored from 340 nm to 550 nm. Spectra were corrected with rhodamen, to 
correct for variations in lamp output. These spectra (Figure 4 and Figure 5) were identical to those 
previously published (1,5). The absorbtion spectra of the product was also taken, and it was 
identical to previously published results (Figure 6) (3). The absorption maximum was seen at 326 
nm, while maximum excitation was seen at 324.5 nm. These maxima are almost identical, and 
their difference is probably due to the instrumentation used to obtain the spectra.
Samples were also injected onto a C-18 reverse phase HPLC with an inner diameter of 4.6 
mm. A flow rate of 1.0 ml/min of acetonitrile/methanol (1/3 v/v) solvent was used (3). Monitoring 
the sample by fluorescent emission at 378 nm after excitation at 327 nm, resulted in a single large 
peak at approximately 9 minutes. Furthermore, monitoring by absorbance at 280 nm and 324 nm, 
also resulted in single peaks at approximately 9 minutes (Figures 7, 8, and 9), These wavelenghts 
were chosen because they are they represent the maximum absorption of ergosterol and 
dehydroergosterol, respectively. Thus, monitoring the sample at 280 nm, the absorption maximum 
for ergosterol, not dehydroergosterol, and only seeing one peak for dehydroergosterol, indicates 
the absence of ergosterol.
Finally, by taking the ratio of the solutions absorbance at 282 nm to its absorbance at 324 
nm, and consulting a standard curve provide by Fischer, et al., it is possible to determine the 
amount of A ^-sterol contamination present in the final product (3). This ratio for the product 
after the HPLC separation was 0.55, or approximately 85 mole % dehydroergosterol; while it was 
0.22 for the product after separation by TIX, or approximately 100 mole % dehydroergosterol.
After purification the concentration of dehydroergosterol was determined by reading the
9absorbance of the product in chloroform at 327.8 nm. Using this and the published value of the 
extinction coefficient, 11200 v H c m 'l , the concentration of dehydroergosterol in chloroform was 
easily obtained (1).
The actual synthesis of dehydroergosterol was relatively easy to accomplish. However, the 
purification of the reaction mixture was not. This was primarily due to the fact that the product, 
dehydroergosterol, differed from the reactant, ergosterol, by only one double bond in the 9 position 
on the sterol ring. After several attempts with varying methods, it was determined that the only 
method of effectively separating product from reactant was by HPLC, as the structural difference 
that was being exploited to achieve this separation was not a major one. The HPLC method used 
was similar to that presented by Fischer (3). This method is very time consuming and relatively 
expensive, but is needed in order to assure complete separation of the dehydroergosterol from the 
ergosterol.
However, use of the time consuming HPLC procedure brought on another problem. As the 
product was being separated, it was exposed to an oxygen atmosphere, which degraded the 
dehydroergosterol. The change here was more pronounced, and it was found that using thin layer 
chromatography with a hexane/diethylether/glacial acetic acid (60/20/1 v/v/v) separated the product 
into two bands, with Rf values of 0.21 and 0.12. The band at the Rf of 0.12 fluoresced with a 
bluish tint, while the one at Rf = 0.21 fluoresced with a greenish tint. Furthermore, iodine staining 
was more intense in the band at Rf = 0.12. Fluorescence emission spectra of the two bands 
confirmed the band at Rf = 0.12 to be the pure dehydroergosterol. The band at Rf = 0.21 is 
believed to be oxidized dehydroergosterol, but this was never confirmed.
With the highly pure dehydroergosterol of known concentration, it is now possible to 
examine the role of cholesterol in a biological membrane, a previously unstudied area in our 
laboratory. The following section of this paper details preliminary investigations with this 
fluorescent probe.
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PRELIMINARY STUDIES WITH 
DEHYPROERGOSTERQLLN 
MQDEL BIOLOGICAL MEMBRANE*
The fluid mosaic model of a biological membrane proposed by Singer describes the 
membrane as a random sea of phospholipids which are free to move laterally (6, 7). Inserted in 
this sea are proteins which are also free to diffuse laterally. However, recent studies have shown 
that the membrane is not completely homogeneous, and that phospholipids and proteins are 
sequestered into different domains within the meniorane.
Recently, fluorescent microscopy has been used to visualize the formation of phospholipid 
domains in vesicles (8). It was found that in vesicles made with 5% fluorescently labeled 
phosphatidic acid (NBD-PA) in 95% phosphatidylcholine (PC), a domain formed in the membrane 
upon the addition of 2 mM Ca^+. This was visualized by the creation of an area in the membrane 
of increased fluorescence intensity. It is believed that the positively charged cation is bridging the 
negatively charged acidic head groups of the phospholipid. This imposes order onto the previously 
random membrane, (rearing two distinct domains in the vesicles, one rich in phosphatidic acid and 
one rich in phosphatidylcholine. Furthermore, it was determined, through polarization studies, that 
the area which was high in phosphatidic acid was more rigid than the phosphatidic acid poor area. 
This conclusion was reached by observing an increase in the polarization of the fluorophore in the 
region of the patch, which indicates that the fluorophore was in an environment that restricted 
random movement of the fluorophore, which, in turn, suggested a less fluid area of the membrane 
(9).
Studies were also carried out in vesicles that contained 65% PC, 5% NBD-PA, and 30% 
cholesterol (8). In these vesicles, the formation of areas of increased fluorescence intensity was
11
also observed, indicating patch formation. However, there was no information concerning the role 
of cholesterol in these vesicles. Through the use dehydroergosterol, one would be able to directly 
observe the role of cholesterol in patch formation in ideal biological membranes (i.e., whether the 
cholesterol was sequestered into the phosphatidic acid domain, excluded from the domain, or 
unaffected by the domain).
Further studies with dehydroergosterol can be carried out in vesicles with different chain 
lengths, and with non-homogeneous chain lengths (vesicles made with phospholipids extracted 
from egg yolk, for example). These would all be valuable in determining the behavior of 
cholesterol in biological membranes.
The results presented here indicate a beginning into the studies that can be carried out with 
dehydroergosterol. When speaking of membrane structure, it is clearly necessary to include all 
membrane components, in order to understand the i>ehavior of the membrane under physiological 
conditions. Dehydroergosterol presents a relatively easy method of studying the behavior of 
cholesterol in the biological membranes, allowing one to obtain a fuller understanding of domain 
formation in membranes and overall membrane structure.
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Materials and Methods
Dioleoylphosphatidic acid (DOPA), dioleoylphosphatidylcholine (DOPC), and their 
fluorescently labeled derivatives, NBD-PA, NBD-PC, DUA-PA, and DUA-PC, were synthesized 
by previously developed procedures from our laboratory.
Large unilamellar vesicle were made by taking a total of 250 nmoles of lipid and 
dehydroergosterol in 0.5 ml water, as per the procedure given by Darszon et al. (8).
Images of the vesicles were taken by an epifluoresccnce microscope, attached to a charged 
coupled device camera and digital image processor, as described by Haverstick and Glaser (8). 
Images were captured by averaging 75 frames of a vesicle, taken at a rate of 30 frames per second. 
The digital processor then applied a pseudo color operation onto the images, which applies color to 
the black and white image as a function of fluorescent intensity. Very low intensity areas of the 
im,tfc. are given a blue color, and as the intensity increases, the color changes to green then yellow, 
with it Teasing intensity, and, the most intense areas of the image, are given a bright red color. All 
figures of vesicles presented here are photographs taken directly from the video monitor with a 
camera equipped with a 90 mm lens.
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Results and Discussion
Preliminary studies were undertaken with dehydroergosterol. These studies were simply 
attempts to visualize the dehydroergosterol with our fluorescent microscope. While this seems 
rather basic, it was very necessary. First, the emission maximum of dehydroergosterol is at 
approximately 376 nm, a wavelength of light that is very far into the blue region of the visible 
spectra, if not into the ultraviolet. Secondly, the microscope did not have built in filter settings that 
would allow the dehydroergosterol to be excited at its maximum and pass its maximum emission. 
Finally, energy in this range is readily absorbed by glass. Thus, the glass cover slips that were 
used to cover the vesicles could be responsible for absorbing a significant amount of the already 
faint fluorescent emission.
Many different filter configurations were tried to bring about the brightest possible emission 
from the dehydroergosterol. In the end, it was determined that the best solution available was to 
use filter block 2 of the microscope, which would permit exciting light down to 345 nm to strike 
the vesicles, and then allow emitted light over 430 nm to pass to the camera, even though the 
excitation and emission maxima of dehydroergosterol are 327 at 376 nm, respectively. It was also 
found that the use of quartz cover slips also improve the signal obtained, and that the lens should 
emersed in glycerol, and not in the oil that was previously used, when it was found that the oil 
absorbed light below 400 to 450 nm very effectively. Both of these changes increased the 
fluorescence seen in the dehydroergosterol vesicles; however, these vesicles were still dim to the 
naked eye, and difficult to observe. This dimness is due to, in a large part, the fact that the 
excitation of, and emission from, the dehydroergosterol are not at their maxima, and substantial 
increases in fluorescence intensity could still be seen by obtaining filters which allowed the passage 
of light closer to the excitation and emission maxima of the fluorophore.
Once the best configuration of the microscope was obtained, studies were begun to observe 
the role of dehydroergosterol during phosphatidic acid domain formation upon the addition of Ca^+
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(2). Originally, it was hoped that the vesicle could be labeled with both the fluorescent 
dehydroergosterol and a fluorescently tagged phospholipid. The advantage of this is readily 
apparent. With double labeled vesicles, one could directly observe the formation of the lipid 
domain, and then compare this to any changes in dehydroergosterol distribution. In our laboratory, 
there are two common fluorescent labels employed for phospholipid, NBD and DUA. The 
emission spectra of DUA is very similar to the dehydroergosterol, and, thus, would not be very 
effective for use with dehydroergosterol, as the emissions from these two compounds could not be 
distinguished. However, NBD labeled phospholipids, with a maximal excitation at approximately 
460 nm and maximal emission at approximately 520 nm, were hoped to be used with the 
dehydroergosterol.
Toward this end, the first determination made was to confirm that the emissions from the two 
fluorophores were distinguishable. Images were obtained of vesicles containing 5 mole % 
dehydroergosterol in DOPC; 5 mole % NBD-PA in DOPC; and 5 mole % dehydroergosterol with 5 
mole % NBD-PA ;n DOPC (Figure 10). These images were obtained under filter blocks 2 and 4 of 
the fluorescent microscope. As has been previously discussed, filter block 2 gave the best results 
for dehydroergosterol, while filter block 4, which permits exciting light of 350-460 nm to reach the 
stage, and passes excited light above 515 nm, has been used for the monitoring of NBD labeled 
phospholipids. As can be seen in figure 10, the vesicle containing only NBD-PA is clearly visible 
with filter block 4 set, and not at all visible with filter block 2. The reverse is true for vesicle 
labeled with dehydroergosterol; they are clearly visible under filter block 2, but not visible under 
filter block 4. Finally, as would be expected, a vesicle labeled with both dehydroergosterol and 
NBD can be seen with both filter blocks 2 and 4. This shows that the microscope is able, through 
the use of the different filter blocks, to distinguish between dehydroergosterol emission and NBD 
emission. From this point, fluorescence obtained through filter block 2 will be referred to as 
fluorescence from the dehydroergosterol position, and the fluorescence obtained through filter
15
block 4 as fluorescence from the NBD position.
These preliminary investigations showed that dehydroergosterol was bleached relatively 
quickly, and that care would have to be taken to make sure that, later, when a vesicle was found to 
study, it was exposed to the high intensity light of the microscope for as short a time as possible.
However, while carrying out these experiments, it was observed that the vesicles that 
contained both dehydroergosterol and NBD appeared brighter under the dehydroergosterol 
position, than the vesicles which contained only dehydroergosterol. There was no noticeable 
difference in the intensities of vesicles, whether or not they contained dehydroergosterol, under the 
NBD position. This seemed to suggest that there might be something other than simple emission 
happening under the dehydroergosterol position when both fluorophores were present in the 
vesicle. Fluorescence emission spectra of vesicles containing only 4 mole % dehydroergosterol in 
DOPC, and vesicles containing both 4 mole % dehydroergosterol and 4 mole % NBD-PA in 
DOPC, at various exciting wavelengths were taken (Figures 11, 12, 13, 14, 15, 16, 17, and IK). 
The emission spectra were taken with the fluorescence microscope in mind. Thus, vesicles were 
e cited at 340 nm and 380 nm, while watching emission above 430 nm, duplicating the excitation 
ai v i ission characteristics of the dehydroergosterol under the dehydroergosterol position (filter 
Y >ck 2 imilarly, excitation at 405 nm and 460 nm, with emission above 510 nm, duplicated the 
v >nditions u ler filter block 4. Figures 19 and 20, the excitation and emission spectra of NBD in 
i hloroform are provided as a reference.
From these >ectra, it is apparent that in the vesicles that contain both dehydroergosterol and 
NBD labeled phospholipid there is significant, if not complete, energy transfer from the excited 
lehydroergostero! to the B Bibel on the phospholipid. This energy transfer is not particularly 
suprising after considcrin u lav hat the emission spectra of dehydroergosterol overlaps with the 
excitation spectra of NBD and that ie tw > tiu< opho > * very close to one another in a 
relatively restricted envi o ment. The t rpv transfer , 'so xpkiins vhy ti e NBD labeled vesicles
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were brighter under the dehydroergosterol position, than the vesicles which only contained 
dehydroergosterol. The double labeled vesicles are emitting a significant percentage of their light at 
higher wavelengths, which are more easily seen, and thus appear brighter, than the vesicles that 
emit all of their light near the ultraviolet end of the visible spectrum.
At first, such significant energy transfer from the dehydroergosterol to the NBD would 
appear to indicate that both probes cannot be used if data on the distribution of dehydroergosterol is 
wanted, because even while using filter block 2 (the dehydroergosterol position), one would 
actually be visualizing the emission from NBD. However, after further consideration, the energy 
transfer from dehydroergosterol to NBD does not completely destroy the possibility of using both 
probes together to obtain data on the distribution of dehydroergosterol in the biological membrane. 
Even though both the dehydroergosterol position and the NBD position provide NBD emission, the 
origin of this emission is from different sources. While using the NBD position, NBD is being 
directly excited, and is then emitting light, allowing one to determine its distribution through the 
vesicle. But, if the vesicle is visualized under the dehydroergosterol position, the 
dehydroergosterol is being excited, transferring its energy to the NBD, which is then emitting; a 
completely different process from the one obtained under the NBD position.
This provides a way of monitoring both NBD and dehydroergosterol, in a limited case.
Using energy transfer as a way of monitoring dehydroergosterol would only be valid if the NBD is 
leaving the area the dehydroergosterol is entering. For example, consider a vesicle with 
dehydroergosterol and NBD-PA. If, upon the addition of calcium, dehydroergosterol leaves the 
area into which the NBD-PA is being sequestered, one could visualize the formation of the PA 
region by directly monitoring NBD fluorescence. Then, if there is enough of the NBD-PA left 
outside the patch, one could visualize, under the dehydroergosterol position, an area in the vesicle's 
membrane where the fluorescent intensity is low. This area of lower intensity under the 
dehydroergosterol position would correspond to the area of increased intensity under the NBD
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position. This would occur due to the method that NBD is being excited before it emits in each 
case. Under the NBD position, NBD is directly excited, so that NBD-PA's distribution in the 
vesicle can be determined form the image obtained. However, under the dehydroergosterol 
position, only NBD that is present in the area that contains dehydroergosterol would emit light. 
Thus, even though there is an area that has a high concentration of NBD label, if the excited 
dehydroergosterol is outside this area, then the emission directly from the dehydroergosterol and 
the emission from the NBD that received its energy from energy transfer from dehydroergosterol 
outside the area of the NBD-PA patch, would be more intense than emission from the high 
concentration of NBD in the patch, causing the NBD-PA rich region to appear less intense.
This is very dependent on the relative concentrations of NBD and dehydroergosterol. If the 
patch appeared in the same place under both the dehydroergosterol and NBD positions, one could 
not be sure of dehydroergosterol's distribution in the membrane. An increase in fluorescence of 
both labels appears in the same area, could be caused by actual sequestering of dehydroergosterol 
into the same region as the NBD, or by the incomplete exclusion of dehydroergosterol from the 
NBD area of the vesicle (i.e., even though the dehydroergosterol is leaving the NBD enriched 
area, this exclusion is not complete, and enough is remaining in the NBD region to make that 
region appear more intense than the rest of the vesicle).
Even with this ambiguity if the patch appears in the same area with both positions, the patch 
appearing in different areas under the two positions would clearly indicate that the 
dehydroergosterol is leaving the area with high NBD concentration. Thus, if the dehydroergoste rol 
appears to be in the same area as NBD-PA, and it is believed that dehydroergosterol is being 
sequestered into this region, making vesicles with NBD-PC should show distinct regions for NBD 
and dehydroergosterol.
Vesicles were then made with 4 mole % dehydroergosterol, 4 mole % NBD-PA, and 92 
mole % DQPC, to examine whether the dehydroergosterol was being excluded from the area of the
IX
phosphatidic acid patch. Images were obtained at time 0 to 2 min, 15 min, and 25 min, under the 
dehydroergosterol and NBD positions for a number of vesicles (Figures 21 and 22). In figures 21, 
and 22, one can clearly see that after 15 minutes in the presence of Ca^+, two distinct regions in the 
membrane form. By watching NBD emission, one sees the actual phosphatidic acid domain 
forming in the vesicles membrane. Then, by examining the vesicle under the dehydroergosterol 
position, one sees a region of increased fluorescence intensity that does not correspond to the area 
of the phosphatidic acid domain. This appears to indicate that the dehydroergosterol is leaving the 
area of the more highly rigid phosphatidic acid domain. Figure 23, is included to show the 
ambiguity that can arise with these double labeled vesicles. After 15 minutes, it appears as if the 
dehydroergosterol is being drawn into the area of the patch. However, this result is probably due 
to the fact that the vesicle was made with 7 mole % dehydroergosterol, and that, even though the 
majority of the dehydroergosterol was excluded from the phosphatidic acid domain, there was 
enough left there to cause significant excitation of the NBD-PA.
Vesicles were also made with 5 mole % dehydroergosterol, 5 mole % DOPA, and 90 mole r/c 
DOPC. These vesicles, as has been previously stated, are much harder to observe, but they can be 
found. Figure 24 is one such vesicle after addition of Ca^+. One can see the formation of a 
domain in the vesicle that is excluding dehydroergosterol. This domain is comparable in size to the 
PA domains in other vesicles with the same percentage of PA. At this time, this event has not been 
observed in a large number of vesicles, but it provides further evidence that the dehydroergosterol 
is being excluded form the highly rigid PA domain.
It was also observed, that when very high concentrations of dehydroergosterol were used 
(30 mole %), vesicles were still difficult to detect by dehydroergosterors emission. This indicated 
that dehydroergosterol might be self-quenching, and when present in these higher concentrations, 
the dim fluorescence that is seen at lower concentrations is lost. To test this, a series of 
experiments was done with the fluorometer.
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First, quantitative data the emission of dehydroergosterol in chloroform at 378 nm after 
excitation at 327.8 nm was obtained. This data is presented in table 1, and is graphed in figmc.>
25A and 25B. The data shows that dehydroergosterol is indeed a self qucnchimz molecule although 
the effect is quite small. This is determined by the fact that as the concentration of 
dehydroergosterol is increased, there is not a corresponding linear increase in the intensity of
emission. Instead, the increases in intensity become smaller with constant increases in 
concentration. The absorbance of the solution at the exciting wavelength (327.8 nm) was also 
checked and kept below 0.10. This was done to insure that fluorescence in the more concentrated 
samples was not being lost due to inner Filter effects.
Furthermore, vesicles were made with 5 mole % DOPA, with increasing amounts of 
dehydroergosterol and decreasing amounts of DOPC. These vesicles were made by drying down 
the components, adding distilled water, vortexing the sample, and then sonicating it for 1 minute. 
The solution was then left undisturbed for 2 hours. The data obtained is presented in table 2, and 
graphed in figure 26. The fluorescence of the vesicles was obtained before and after addition of 
Triton X-100. Triton X-100 is able to disrupt the phospholipid bilayer, thus freeing its 
components. Therefore, the fluorescence observed before addition of Triton X-100 is from 
dehydroergosterol that is in the bilayer, while the fluorescence after is from dehydroergosterol in 
Triton X- 1(X) micelles When dehydroergosterol is confined to the bilayer it has less space available 
to it and is more concentrated. Thus, when it is solubilized by Triton X-100, it becomes less 
concentrated, and less likely to self-quench. In Figure 26 an increase in fluorescence is seen after 
addition of Triton X-l(X), indicating that dehydroergosterol is indeed self-quenching. This increase 
is not an artifact produced by light scattering in solution, as the absorbances before and after the 
addition of Triton X-100 were the same (Table 2), Finally, there does not appear to be an increased 
quantum yield of dehydroergosterol in the Triton X-100 micelles. However, there may be a 
decreased quantum yield in the micelles, which would increase the change in flourescence observed
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upon addition of Triton X-100, but more work is needed to confirm this.
After it was determined that the dehydroergosterol does quench, vesicles were made with 5 
mole % dehydroergosterol, 5 mole % DOPA, and 90 mole % DOPC. These vesicles then had 
either 3 mM Ca^+ or distilled water added to them and they were watched over time in the 
fluorometer (Table 3 and Figure 27). The vesicles that had water added to them retained a constant, 
or nearly constant, fluorescence intensity over time, or a slightly diminished intensity due to 
bleaching of the fluorophore. Vesicles that had calcium added lost a significant amount of 
fluorescence, over the water controls. Again absorbances were determined to make sure they were 
below 0.10, and the absorbance change was detemiined to be below 0.030, to rule out light 
scattering in the solution as the cause of the decrease in fluorescence. The decrease in fluorescence 
in the vesicles to which calcium had been added, coupled with the knowledge that 
dehydroergosterol self quenches, provides further evidence that the dehydroergosterol is 
undergoing a change in the membrane, but does not provide information about whether it is being 
included or excluded from the phosphatidic acid domain.
This conclusion is reached by realizing that when the intensity of dehydroergosterol emission 
goes down, the dehydroergosterol must be quenching itself, which requires a higher concentration 
of dehydroergosterol. Thus, when the membrane is reorganized by calcium, the concentration of 
dehydroergosterol in the membrane must be going up. Since there has been no change in the 
amount of dehydroergosterol present, the only way to have an increase in concentration is by 
forcing what is already present to occupy less area. Therefore, the dehydroergosterol is being 
confined to a particular area, or domain, in the membrane.
Taken together, this data provides rather conclusive evidence concerning the distribution of 
dehydroergosterol after a phosphatidic acid domain has been formed with calcium. However, more 
work must be done to confirm these results and ensure that they are repeatable.
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CONCLUSION
The results presented here are a beginning in the kinds of studies that can be done with 
dehydroergosterol, a very useful fluorescent probe for cholesterol. In fact, many studies have to 
been done before any final conclusions have can be drawn about cholesterol's role in the 
membrane. Some experiments that could be easily accomplished currently include changing the 
amounts and types of phospholipids in the membrane, as well as the concentration of cholesterol 
present in the membrane.
Knowledge of the structure and distribution of phospholipids and other components in the 
biological membrane could provide insight into many cellular processes that deal with the 
membrane, such as fusion of sperm and egg during fertilization, endocytosis in microbes, and 
exocytosis causing neurotransmitter release in axons. Dehydroergosterol provides a very' efficient 
and direct means of studying one of these membrane components, and may provide great insight 
into the molecular mechanisms of membrane mediated cellular events.
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Table 1: Quenching data 
DATA SET 1
Concentration Fluorescence
(mM) (excitation 327.8 nm/ 
emission 378.0 nm)
0.00129
0.00193
0.00257
0.00321
0.00386
0.00450
0.00514
DATA SET 2:
203.724
352.853
445.852
541.549
641.848
719.352
759.897
Concentration
(mM)
Fluorescence 
(excitation 327.8 nm/ 
emission 378.0 nm)
0.00257
0.00514
0.00771
0.00154
508.735
824.620
1311.327
1703.856
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Table 2; Quenching in Vesicles Upon Addition of Triton X-100
Mole % Fluorescence
Dehydroergosterol Before Triton
(327.8 nm/378.0 nm)
0.25
1.0
3.0
5.0
10.0
65.427
262.166
348.357
937.706
1490.437
Mole % Absorbance 327.8 nm
Dehydroergosterol Before Triton
0.25 0.022
1.0 0.023
3.0 0.103
5.0 0.100
10.0 0.259
Fluorescence 
After Triton 
(327.8 nm/378.0 nm)
129.891
378.953
1008.731
1479.729
2541.254
Absorbance 327.8 nm 
After Triton
0.014
0.016
0.084
0.111
0.262
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Table 3: Quenching Upon Addition of Calcium
Time Vesicles with 0 mM Vesicles with 3 mM
(minutes) Calcium Added Calcium Added
(327.8 nm/378.0 nm) (327.8 nm/378.0 nm
0 1741.426 1583.717
15 761.931 1329.998
30 632.074 1136.321
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l-'igurc 4:
Fluorescence excitation spectra of dchydroergosterol in ethanol. Hmission was
monitored at 380 nm. The maximum excitation is seen at 325.0 nm.
1)0.00
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Fluorescence emission spectra of dchydrocrgosterol in ethanol. Sample was 
excited at 320 nm. Maximum emission at 371 nm.
Figure 5:
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Figure 6:
Absorption spectra ofdchydroerjiosterol in ethanol. 'Hie maximum absorbance
is seen at 326 nm.
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Figure 7;
Fluorescently monitored IIPLC run of pure dehydrocrgostcrol (4.6 mm inner 
diameter by 250 mm C-18 HPLC column, 10 (il injection, mcthanol/acetouitrile (3/1 
v/v) solvent system, flow of 1.0 ml/min). Monitored fluorescently with excitation at 
324 nm, and emission at 376 nm. 'Hie small peak at 14.11 min. is due to 
contamination in the chloroform solvent.
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HPLC run of pure dehydroergostcrol (4.6 mm inner diameter by 250 mm C-18 
HPI.C column, 10 pi injection, methanol/acctonitrile (3/1 v/v) solvent system, flow 
of 1.0 ml/min). Monitored by absorbance at 280 nm. The small peaks early in the 
run are due to chloroform.
Figure 8:
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HPLC run of pure dehydroergosterol (4.6 mm inner diameter by 250 mm C-18 
HPLC column, 10 jil injection, methanol/acetonitrile (3/1 v/v) solvent system, flow 
of 1.0 ml/min). Monitored by absorbance at 324 nm. The small peaks early in the 
run are due to chloroform.
Hpure 9:
3
r I 'm iv i n
V i M u l i / a i v n  m| < j 
h>v Vnt>!i‘ M i l  > PA 1:1 os 
i |p|l\ dh ' P! "MsliTnl ,ii a I  ^ 11 m!,-
' I ’ l '' ! V ‘ I i ) 1 \  , ‘ i v j. ‘ , , j i : • ,1 , ! I ! I ; t '• V. ; i ’ j 1 j j : ;
11 m 1 k ' - 1 ^ ) } 1 ( , 1 < > j  ^ j ', i ! i s11. k  • ’ ! i >i ; \ j () v, , 'N i ■ ,. ■;
* M i l ) PA 111 Al l  Mink' A I M ) | J( ' n! iv I P ,, i • • v  ;
|p > ' 11 i m i 1 has ,i \ p r\ Iup11 k u  k n mml p vnA k  >i I» u11 p,tripk  ^ 11u »|p A 
deh\ droergostpn >| m AS mnk* A I )OP( I v l i  hand mupps aip w nh p< isn m ;, 1 
olphydroergosterol position), and right hand images are with position 4 (Mil)  
position).
r v
f
i
v
32
Figure 11:
Emission spectra of vesicles containing NBD-PA and dehydrocrgostcro!.
Excitation at 340 nm. Note the absence of dehydroergosterol fluorescence.
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Figure 12:
Emission spectra of vesicles containing NBD-PA and dehydroergostcrol.
Excitation at 380 nm. Note the absence of dehydroergostcrol fluorescence.
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Figure 13:
[emission spectra of vesicles containing NBD-PA and dehydroergostcrol.
Hxcitation at 405 nm.
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Figure 14:
and dehydroergosterol.
Excitation at 460 nm,
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Figure 15:
Emission spectra of vesicles containing dchydrocrg< sterol. Excitation at 340
urn.
n. nr;: nn .
ur;. on
-» ♦ j t ♦
sun.on
N <.1 V< ‘ I < * I If | f I I f Min
t • I
I
//.ID. no
37
Figure 16:
Emission spectra of vesicles containing dehydroergosterol. Excitation at 380
nm.
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Figure 17:
Emission spectra of vesicles containing dehydroergosterol. Excitation at 405
nm.
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Figure 18:
Emission spectra of vesicles containing dehydrocrgosterol. Excitation at 460
nm.
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Fluorescence excitation spectra of NBD in chloroform. Emission was 
monitored at 520 nm.
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Fluorescence emission spectra of NBD in chloroform. Sample was excited at 
460 nm.
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liig yirg 21;
Vesicle containing 4 mole %  dchydroergostcrol, 4 mole % NBD-PA, and 92 
mole %  DOPC. Top row is at 0 to 2 minutes after addition of Ca , bottom row is 
15 to 20 minutes after addition. I^eft hand images are with dehydroergosterol 
position, and right hand images are with NBD position. Note the exclusion of 
dehydroergosterol from the PA domain. This is difficult to see, as the vesicle became 
very dim overtime.
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Second set of images. Vesicle containing 4 mole dehydrocrgosterol, 4 mole 
% NBD-PA, and 92 mole % DOPC. Top row is at 0 to 2 minutes after addition of 
Ca^+, bottom row is 15 to 20 minutes after addition. Ix'ft hand images are with 
dehydrocrgosterol position, and right hand images arc with NBD position. Note the 
exclusion of dehydrocrgosterol from the PA domain. 'Hie NBD images are dim due 
to the use of a neutral density filter.
r etire 22:
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l i g n r e  23:
Vesicle containing 7 mole '/< dehydroergosternl, 5 mole 'Z  NHD-I’A. and SS 
mole (Z  DOPC. 'I’op row is at 0 to 5 minutes after addition of Ca~f , bottom row is
15 to 20 minutes after addition, lx*ft hand imaees are w ith dehydroeruosterol 
position, and right hand images are with NBl) position. Notice that w ith the added 
dehydroergosterol, the patches appear to coincide.
/
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Figure 24:
Vesicle containing 5 mole (7< dehydroergosterol and 5 mole 7  DOPA in ‘>0 mo 
<7< DOPC. Top left-hand image is at 0 to 5 minutes after addition of C \r+ . bottom 
left-hand image is 15 to 20 minutes after addition. Images are with 
dehydroergosterol position. Note the exclusion of dehydroergosterol from the 
upper-right area of the vesicle. 'ITie image on the right is taken with phase contrast 
microscopy, and is presented to show that the vesside is not multilamellar.
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Self quenching of deliydroergosterol in chloroform. This is indicated by the fac 
that there is not a linear relation between fluorescence and concentration, as the 
concentration is increased. Both data sets are plotted.
Figure 25A:
Dehydroergosterol Quenching 
in Chloroform - Data Set 1
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Figure 25B:
Dehydroergosterol Quenching 
in Chloroform - Data Set 2
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Fluorescence increase of dehydroergosterol after disruption of vesicles with 
Triton X-100. Final Trition concentration was 1 % . Vesicles were prepared with 5 
mole % DOPA, the indicated precentage of dehydroergosterol, and the remaining 
precentage DOPC. At 1 % dehydroergosterol there is a 44,5 %  increase in 
fluorescence intensity upon addition of Triton X-100; at 5 % dehydroergosterol the 
increase is 57.8 %; and at 10 % dehydroergosterol the increase is 70.5 %.
Figure 26;
Dehydroergosterol Fluorescence 
Upon Addition of Triton X -100
After Triton 
Addition
Before Triton 
Addition
Figure 27;
Decrease in fluorescence of vesicles upon addition of calcium. Vesicles were 
made with 5 mole %  DOPA, 5 mole %  dehydroergosterol, and 90 mole % DOPC. 
Vesicle solutions had either distilled water or calcium solution added. Notice that 
after 15 and 25 minutes, the vesicle solution that had C e r +  added has a significantly 
greater drop in fluorescence than the vesicle solution to which water was added. The 
decrease in the fluorescence of the control is due to bleaching of the fluorophorc.
T,essicle Fluorescence After 
Addition of Calcium
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